Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Clinical assessment and validation of a rapid and sensitive SARS-CoV-2 test using reverse-transcription loop-mediated isothermal amplification

View ORCID ProfileMelis N. Anahtar, Graham E.G. McGrath, View ORCID ProfileBrian A. Rabe, Nathan A. Tanner, Benjamin A. White, Jochen K.M. Lennerz, John A. Branda, View ORCID ProfileConstance L. Cepko, Eric S. Rosenberg
doi: https://doi.org/10.1101/2020.05.12.20095638
Melis N. Anahtar
1Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Melis N. Anahtar
Graham E.G. McGrath
2Department of Medicine, Massachusetts General Hospital, Boston, MA 02114
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian A. Rabe
3Departments of Genetics and Ophthalmology, Harvard Medical School, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brian A. Rabe
Nathan A. Tanner
4New England Biolabs, Ipswich, MA 01938
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin A. White
2Department of Medicine, Massachusetts General Hospital, Boston, MA 02114
5Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA 02114
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jochen K.M. Lennerz
1Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John A. Branda
1Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Constance L. Cepko
3Departments of Genetics and Ophthalmology, Harvard Medical School, Boston, MA 02115
6Howard Hughes Medical Institute, Chevy Chase, MD 20815
7Blavatnik Institute, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Constance L. Cepko
Eric S. Rosenberg
1Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114
2Department of Medicine, Massachusetts General Hospital, Boston, MA 02114
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Amid the enduring COVID-19 pandemic, there is an urgent need for expanded access to rapid and sensitive SARS-CoV-2 testing worldwide. Here we present a simple clinical workflow that uses a sensitive and highly specific colorimetric reverse-transcription loop-mediated isothermal amplification (RT-LAMP) to detect SARS-CoV-2 and takes forty minutes from sample collection to result. This test requires no specialized equipment and costs a few dollars per sample. Nasopharyngeal samples collected in saline were added either directly (unprocessed) to RT-LAMP reactions or first inactivated by a combined chemical and heat treatment step to inhibit RNases and lyse virions and human cells. The specimens were then amplified with two SARS-CoV-2-specific primer sets and an internal specimen control; the resulting color change was visually interpreted. While direct addition of unprocessed specimens to RT-LAMP reactions could reliably detect samples with abundant SARS-CoV-2, the assay sensitivity markedly increased after the addition of an inactivation step. In 62 clinical samples with a wide range of SARS-CoV-2 nucleic acid concentrations, the assay had 87.5% sensitivity and 100% specificity with a limit of detection at least 25 copies/μL, making it an ideal test to rule in infection. To increase sensitivity, samples that tested negative for SARS-CoV-2 by direct sample addition could be reflexed to a purification step, to increase the effective per-reaction sample input volume. In 40 purified samples, the assay yielded a 90% sensitivity and 100% specificity, with a limit of detection comparable to commercially available real-time PCR-based diagnostics that have received Emergency Use Authorization (EUA) from the FDA. This test for SARS-CoV-2 can be performed in a range of settings for a fraction of the price of other available tests, with limited equipment, and without relying on over-burdened supply chains to increase overall testing capacity.

Competing Interest Statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: M.N.A is a co-founder and holds equity interest in Day Zero Diagnostics, outside of submitted work. N.A.T. is on multiple patents related to pH-based amplification detection and DNA polymerases. J.A.B. reports grants from Zeus Scientific, grants from bioMerieux, grants from Immunetics, personal fees from T2 Biosystems, personal fees from DiaSorin, personal fees from Roche Diagnostics, grants from Bay Area Lyme Foundation, grants from Lyme Disease Biobank Foundation, outside the submitted work. Harvard University has filed patent applications regarding this technology on behalf of the inventors. Harvard believes strongly that while intellectual property rights serve to incentivize creation of new products, such rights should not become a barrier to addressing urgent and essential health-related needs. To address the global COVID-19 pandemic, Harvard is implementing technology transfer strategies to allow for rapid utilization of available technologies that may be useful for preventing, diagnosing and treating COVID-19 infection. More information can be found at otd.harvard.edu.

Funding Statement

B.A.R. and C.L.C. are supported by the Howard Hughes Medical Institute. N.A.T. is an employee of New England Biolabs, manufacturer of enzymes and reagent described in this manuscript

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data available within the article or its supplementary materials.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Clinical assessment and validation of a rapid and sensitive SARS-CoV-2 test using reverse-transcription loop-mediated isothermal amplification
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinical assessment and validation of a rapid and sensitive SARS-CoV-2 test using reverse-transcription loop-mediated isothermal amplification
Melis N. Anahtar, Graham E.G. McGrath, Brian A. Rabe, Nathan A. Tanner, Benjamin A. White, Jochen K.M. Lennerz, John A. Branda, Constance L. Cepko, Eric S. Rosenberg
medRxiv 2020.05.12.20095638; doi: https://doi.org/10.1101/2020.05.12.20095638
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Clinical assessment and validation of a rapid and sensitive SARS-CoV-2 test using reverse-transcription loop-mediated isothermal amplification
Melis N. Anahtar, Graham E.G. McGrath, Brian A. Rabe, Nathan A. Tanner, Benjamin A. White, Jochen K.M. Lennerz, John A. Branda, Constance L. Cepko, Eric S. Rosenberg
medRxiv 2020.05.12.20095638; doi: https://doi.org/10.1101/2020.05.12.20095638

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1097)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9774)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2313)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1562)
  • Health Policy (736)
  • Health Systems and Quality Improvement (604)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11650)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1180)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4663)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)